search

Active clinical trials for "Carcinoma, Renal Cell"

Results 1171-1180 of 1644

Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer

CarcinomaRenal Cell3 more

The purpose of this study is to find out if renal cell (kidney) cancer that has spread to other parts of the body will respond to treatment with motexafin gadolinium (MGd).

Completed17 enrollment criteria

Using Virtual Reality (VR) Models for Preoperative Planning

Kidney CancerRenal Cell Carcinoma

A prospective, randomized, controlled study designed to assess whether digital virtual reality (VR) models, created from existing CT scans and MRIs, provide surgeons with an improved understanding of their patients' anatomy, resulting in more efficient operations (robotic partial nephrectomy) and improved patient care.

Completed6 enrollment criteria

MRI Study of BAY 43-9006 in Metastatic Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma

The purpose of this study is to determine maximum tumor shrinkage, time to progression, survival, drug concentration, and degree of skin toxicity.

Completed14 enrollment criteria

Phase II Clinical Trial of Gemcitabine and Doxil® for Metastatic Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma

The purpose of this study is to test the hypothesis that the combination of gemcitabine and doxil will have clinical activity in patients with metastatic renal cell carcinoma.

Completed30 enrollment criteria

Mechanism of Action Trial of ColoAd1

Resectable Colon CancerResectable Non-small Cell Lung Cancer2 more

To assess the pattern of ColoAd1 viral delivery and viral expression within colon tumour tissue when administered by intra-tumoural injection or within colon, non-small cell lung, bladder and renal cell tumour tissues following ColoAd1 administration by intravenous infusion.

Completed49 enrollment criteria

Outcome-related Factors in Patients With Metastatic Renal Cell Carcinoma Treated With Everolimus...

Renal Cell Carcinoma

Evaluation of unfavourable outcome-related factors in patients affected by renal cell cancer in treatment with everolimus and previously treated with a Vascular endothelial growth factor (VEGF) inhibitor (i.e. sunitinib, sorafenib,pazopanib, or bevacizumab+interferon)

Terminated22 enrollment criteria

Mobile Intervention - Physical Activity in Cancer Treatment

CarcinomaRenal Cell

Aim 1. Determine the feasibility and acceptability of the proposed mobile technology intervention to increase physical activity patients receiving treatment for renal cell carcinoma. Aim 2. Evaluate the effect of the proposed intervention components (affective framing, intention planning, and goal-setting) on changes in physical activity.

Terminated7 enrollment criteria

Sunitinib Malate Related Fatigue in Patients With Metastatic Kidney Cancer

FatigueRecurrent Renal Cell Cancer1 more

The purpose of this research study is to determine how sunitinib (sunitinib malate) causes fatigue. Patients will be asked to complete a brief questionnaire (survey) to rate their levels of fatigue every two weeks while they are participating in this research study. The questionnaire takes approximately 10-15 minutes to complete and is 9 questions. A series of physical measurements for fatigue will be performed before the first dose of sunitinib and again (4) weeks later to see if there are any changes in physical level of fatigues

Terminated26 enrollment criteria

Evaluation of Predictive Markers for Toxicity and Efficacy in Patients With mccRCC Treated by Anti-VEGF...

Clear-cell Metastatic Renal Cell Carcinoma

The purpose of this study is to assess whether certain metabonomics and/or lipidomics features in correlation with pharmacokinetics before, during and after treatment with sunitinib or pazopanib in first line can predict toxicity and efficacy of sunitinib or pazopanib in metastatic clear cell renal cell carcinoma patients.

Terminated16 enrollment criteria

Hepatic and Renal Thermography Using Magnetic Resonance Imaging

Liver TumorsKidney Carcinoma

Several technological challenges exist to apply Magnetic Resonance guided High Intensity Focused Ultrasound (MRgHIFU) for treatment of liver or kidney in particular challenges related to the motion of these organs. This study tests a new software to improve thermometry accuracy in mobile organs in patients with liver or kidney tumors. In the same time, the trajectory of the target in 3D is analyzed.

Terminated8 enrollment criteria
1...117118119...165

Need Help? Contact our team!


We'll reach out to this number within 24 hrs